Multi-cell sealed container
09987194 ยท 2018-06-05
Assignee
Inventors
- William J. Havel (West Lafayette, IN, US)
- Neal E. Fearnot (West Lafayette, IN, US)
- Peter S. McKinnis (West Lafayette, IN, US)
- Richard B. Sisken (West Lafayette, IN, US)
- Charles Leland Baxter (West Lafayette, IN, US)
Cpc classification
B65D75/44
PERFORMING OPERATIONS; TRANSPORTING
B29C65/02
PERFORMING OPERATIONS; TRANSPORTING
B29C65/14
PERFORMING OPERATIONS; TRANSPORTING
B29C66/8322
PERFORMING OPERATIONS; TRANSPORTING
A61J1/2093
HUMAN NECESSITIES
B29K2023/083
PERFORMING OPERATIONS; TRANSPORTING
B29C65/4895
PERFORMING OPERATIONS; TRANSPORTING
B65D75/5883
PERFORMING OPERATIONS; TRANSPORTING
B29C66/3452
PERFORMING OPERATIONS; TRANSPORTING
B29C65/04
PERFORMING OPERATIONS; TRANSPORTING
B29C66/43121
PERFORMING OPERATIONS; TRANSPORTING
B29C66/1122
PERFORMING OPERATIONS; TRANSPORTING
B29K2075/00
PERFORMING OPERATIONS; TRANSPORTING
B29C66/7212
PERFORMING OPERATIONS; TRANSPORTING
B29C66/71
PERFORMING OPERATIONS; TRANSPORTING
B29C66/71
PERFORMING OPERATIONS; TRANSPORTING
B29C66/344
PERFORMING OPERATIONS; TRANSPORTING
B29C65/48
PERFORMING OPERATIONS; TRANSPORTING
B29C66/8266
PERFORMING OPERATIONS; TRANSPORTING
B29K2075/00
PERFORMING OPERATIONS; TRANSPORTING
B29C66/7212
PERFORMING OPERATIONS; TRANSPORTING
B29K2023/083
PERFORMING OPERATIONS; TRANSPORTING
B65D75/42
PERFORMING OPERATIONS; TRANSPORTING
A61J1/1468
HUMAN NECESSITIES
B65B51/26
PERFORMING OPERATIONS; TRANSPORTING
B29C66/73921
PERFORMING OPERATIONS; TRANSPORTING
B29C65/10
PERFORMING OPERATIONS; TRANSPORTING
International classification
B65D75/42
PERFORMING OPERATIONS; TRANSPORTING
B65D75/44
PERFORMING OPERATIONS; TRANSPORTING
B29C65/02
PERFORMING OPERATIONS; TRANSPORTING
B29C65/00
PERFORMING OPERATIONS; TRANSPORTING
B65B51/26
PERFORMING OPERATIONS; TRANSPORTING
A61J1/20
HUMAN NECESSITIES
Abstract
Described in one aspect is a multi-cell or multi-chambered container for sealing various materials such as therapeutic or diagnostic agents, animal or human tissue, tissue samples, specimens, blood, genetic material, or any other material. The container includes seals formed by folding the wall of the elongate body transverse to the interior of the elongate body and maintaining the folded wall portions adjacent one another or joining them together. In another aspect, the container disclosed may be made according to a method involving creating multiple seals at various locations along the elongate body thus creating sealed voids or cells between the seals within the elongate body.
Claims
1. A container, comprising: an elongate body with a first, second, and third seal at three separate locations respectively along the elongate body defining a first hermetically sealed void within the elongate body between the first and second seals, and a second hermetically sealed void within the elongate body between the second and third seals; wherein at least one of the first or second hermetically sealed voids contains a therapeutic or diagnostic agent; wherein the elongate body has a wall defining an interior lumen that has an inner surface; wherein the first seal includes a plurality of folds in the wall defining corresponding sealing portions of the wall; wherein the sealing portions extend transverse to the interior lumen; and wherein the sealing portions are joined to one another to form the first seal, and wherein the first seal, the second seal, and/or the third seal each includes at least three folds defining at least three sealing portions per seal, the sealing portions extending transverse to the interior lumen in different directions, and wherein the sealing portions are on the inner surface of the interior lumen.
2. The container of claim 1, wherein an interior width of the interior lumen at a location adjacent the first, second, or third seal is narrower than the interior width at a location other than adjacent the first, second, and third seal locations.
3. The container of claim 1, wherein the wall of the elongate member includes a thermoplastic polymeric material.
4. The container of claim 1, further comprising: a fourth seal at a fourth separate locations along the elongate body defining a third hermetically sealed void within the elongate body between the third and fourth seals; wherein the second hermetically sealed void contains a therapeutic or diagnostic agent; wherein the first and third hermetically sealed voids do not contain a therapeutic or diagnostic agent; and wherein the fourth seal includes at least three folds in the wall defining at least three sealing portions extending transverse to the interior lumen in different directions, and wherein the at least three sealing portions of the fourth seal are fused together to form a unitary structure.
5. The container of claim 1, wherein the therapeutic or diagnostic agent includes cells.
6. The container of claim 3, wherein the thermoplastic polymeric material is Ethylene-Vinyl Acetate (EVA).
7. The container of claim 1, wherein the sealing portions of the wall are contiguous with the wall.
8. A container, comprising: an elongate body with a first, second, and third seal at three separate locations respectively along the elongate body defining a first hermetically sealed void within the elongate body between the first and second seals, and a second hermetically sealed void within the elongate body between the second and third seals; wherein the first hermetically sealed void maintains a sterile puncture site through the second seal into the second hermetically sealed void; wherein the second hermetically sealed void contains a biological material comprising cells; wherein the elongate body has a wall defining an interior lumen that has an inner surface; wherein the first seal includes a plurality of folds in the wall defining corresponding sealing portions of the wall; wherein the sealing portions extend transverse to the interior lumen; wherein the sealing portions are joined to one another to form the first seal; and a fourth seal at a fourth separate location along the elongate body defining a third hermetically sealed void within the elongate body between the third and fourth seals; wherein the third hermetically sealed void maintains a sterile puncture site through the third seal into the second hermetically sealed void and does not contain a therapeutic or diagnostic agent; and wherein the fourth seal includes at least three folds in the wall defining at least three sealing portions extending transverse to the interior lumen in different directions, and wherein the at least three sealing portions of the fourth seal are fused together to form a unitary structure.
9. The container of claim 8, wherein the wall of the elongate member includes a thermoplastic polymeric material.
10. The container of claim 8, wherein the sealing portions of the wall are contiguous with the wall.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
(1)
(2)
(3)
(4)
(5)
(6)
REFERENCE TO RELATED APPLICATION
(7) The present application claims the benefit of U.S. Provisional Patent Application No. 62/041,820 filed Aug. 26, 2014 which is incorporated herein by reference in its entirety.
DETAILED DESCRIPTION
(8) For the purpose of promoting an understanding of the principles of the invention, reference will now be made to the examples illustrated in the drawings and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended. Any alterations and further modifications in the described examples, and any further applications of the principles of the invention as described herein are contemplated as would normally occur to one skilled in the art to which the invention relates. One or more examples of the invention is shown in great detail, although it will be apparent to those skilled in the relevant art that some features that are not relevant to the present disclosure may not be shown for the sake of clarity.
(9) The reference numerals in the following description have been organized to aid the reader in quickly identifying the drawings where various components are first shown. In particular, the drawing in which an element first appears is typically indicated by the left-most digit(s) in the corresponding reference number. For example, an element identified by a 100 series reference numeral will first appear in
(10) One example of a container is illustrated in
(11) Container 100 may terminate at seals 105 and 120, or may include additional lengths of elongate body 150 defining extensions or additional lengths 155 and 160. Extensions 155 and 160 may extend longitudinally beyond seals 105 and 120 away from voids 125 and 135 respectively. Extensions 155 and 160 are optional elements which may provide additional support and protection for seals 105 and 120, or aid in handling, manufacturing, or storage of container 100.
(12) Seals 105, 110, 115, and 120, as well as other seals described herein may be fluid tight or hermetic seals thus making it possible to hermetically seal voids such as 125, 130, 135 and any other voids that may be created by additional seals formed along elongate body 150. Thus the seals disclosed herein can reduce or eliminate the transfer of fluid or other substances from one void to another. In one example, one of the voids, such as void 130 may contain a specimen, sample, or other substance 140 which may be a fluid such as a gas or a liquid, or it may be a solid as well. For example, container 100 with fluid contents 140 in a liquid state may be placed in a cool environment possibly causing the contents of fluid 140 to condense changing state from a gas or vapor to a liquid phase fluid. Container 100 may also be placed in an environment that is colder still causing the gas or liquid phase fluid contents 140 to change phase to a solid. In another example, Container 100 may be subjected to extremely cold temperatures such as by partially or completely immersing container 100 in a cryogenic freezing environment such as a liquid nitrogen bath which may also cause fluid 140 to change phase to a solid. Contents 140 may be maintained in the solid phase, such as during storage or transportation, before later being thawed to a liquid phase, or vaporized to a gaseous phase within void 130.
(13)
(14) As shown in
(15) Various configurations of wall 145 are also envisioned. For example, wall 145 may be a single wall extending around the perimeter of elongate body 150. Wall 145 may be substantially circular, ovular, or may be some other curvilinear shape depending on the cross-sectional shape of elongate body 150. In another example, wall 145 may be composed of several segments or sides with corners or vertices, such as where elongate body 150 has a square, rectangular, hexagonal, or other multi-sided polygonal cross-sectional shape. Where other cross-sectional shapes are involved, the perimeter of wall 145 may be considered a single wall made up of multiple sides or segments with a perimeter of elongate body 150 that includes the outer surface of the various segments. Therefore the use of the term wall with respect to the disclosed examples and embodiments includes a single wall, a single wall with any number of sides, or a wall comprising multiple wall segments.
(16) Any of the seals discussed herein, such as seals 105, 110, 115, and 120, may be formed as illustrated in
(17) Exemplary seals 200A and 200B are illustrated in
(18) Sealing portion 265 can extend inwardly from all around the perimeter of elongate body 150 in a direction across interior lumen 250. This sealing portion may be formed by folds or portions of wall 145 folded inwardly to extend across lumen 250. Closure 265 may be formed by two folds, three folds, or four or more folds compressing wall 145 inwardly toward longitudinal axis 215. In another example illustrated in
(19) The inward folding of wall 145 can create a concave region 245 along outside surface 275 corresponding with the narrowing of elongate body 150 at sealing portion 265. The concave region 245 creates shoulders or shoulder regions 255 and 260. The corresponding concave region 245 and shoulder regions 255 and 260 define a narrowing region 210 in elongate body 150 as wall 145 is maintained or joined internally across the longitudinal axis 215 and extends inwardly from multiple directions around the perimeter of elongate body 150. The inward fold 245 may also define internal concave regions 235 and 240. These regions may, for example, be formed on opposite sides of seals 200A or 200B and may also define the ends of opposing voids 225 and 230 where closure 265 separates lumen 250 to create the ends of voids 225 and 230.
(20)
(21) Some examples of modifying elongate body 150 to form a seal according to the seals described and illustrated herein are illustrated in
(22)
(23) Closure 265 may also be formed by applying heat 410 as well as compression forces 405 and 415. Heat 410 may be optionally applied to wall 145 for the purpose of adhering, bonding, or fusing wall material together to form closure 265. As illustrated in
(24) Forces 405 and 415 may be useful to bring additional wall material from wall 145 into the narrowing region 210 for the purpose of creating closure 265. For example, in the case where heat 410 is applied, wall material in wall 145 may soften in the area of narrowing region 210 allowing additional wall material to flow into the area of narrowing region 210. This additional wall material may be supplied by the surrounding wall 145 as it is compressed toward narrowing region 210 by compression forces 415. The additional material may be useful in creating seal like seal 200A from wall material and contiguous with wall 145 as illustrated in
(25) Compression forces 410 may also be applied along with a twisting force to elongate body 150 around longitudinal axis 215 focusing the torque on elongate body 150 on narrowing region 210 where closure 265 is to form. Also, a second twisting force in an opposite direction from the first force may be optionally applied on the opposite side of narrowing region 210 as well to further aid in the compression of wall 145. Heat 405 may be applied as the twisting forces are applied as well, and the optional compression by forces 415 may also be applied as discussed above. The combination of heat 410, compression 415, and twisting force applied to elongate body 150 can be used together to create closure 265 at narrowing region 210.
(26) In another example, a compression device contacting some or all of outside surface 275 may apply compression forces 405 substantially evenly from substantially all directions with or without twisting elongate body 150. Similarly, as will be discussed below, the compression device may compress outside surface 275 inwardly by forces 405 from three locations around the perimeter of elongate body 150, or from four locations, or more resulting in a seal similar to seal 200A appearing in
(27)
(28) Sealing portions 505 of interior surfaces 270 may be joined together to form the closure 265. Sealing portions 505 may be joined together by any suitable technique such as by melding or fusing wall 145 together to form closure 265. Other exemplary techniques for joining sealing portions 505 together include ultrasonic welding, heat, solvents, or other similar agents or techniques. In these examples, sealing portions 505 of interior surfaces 270 may no longer be separately identifiable in the finished closure 265 as wall material from sealing portions 505 may be blended to form a single unitary structure 265 contiguous with wall 145. In another example, sealing portions 505 may be adhered together with any suitable adhesive, a process which can join sealing portions 505 while maintaining the separate structural properties of wall 145 intact (such as interior surfaces 270) that define sealing portions 505. In this case, interior sealing portion surfaces 270 may continue to be separate identifiable structures while remaining joined together in a sealing relationship to hermetically seal lumen 250 as discussed herein elsewhere.
(29) As illustrated in
(30) Another example of a series of actions that may be taken to form a seal like seal 200B is shown in
(31) As illustrated in
(32) In
(33) Illustrated in
(34) In
(35) The process is further illustrated in
(36) In
(37) In
(38) As shown in
(39) The seals disclosed herein may be created along the tubing at various points by squeezing, crimping, or otherwise compressing the wall of the tubing at the location where a seal is to be made, and then bonding the internal sealing surfaces of the tube walls together by any suitable means such as by heat, adhesives, solvents, and the like. Seal 120 can be formed first, followed by seal 115 thereby creating a void 135. The specimen or other contents of the container may be introduced into the open void 130, and then void 130 may be sealed by the creation of another seal 110. Lastly, a seal 105 may be formed enclosing a void 125. During the process of filling and sealing the contents 140, container 100 may be maintained in a substantially sterile environment. Thus the contents 140, as well as the inside surfaces 1105, 1110, and 1115 can also be substantially sterile. Container 100 may then be separated from the longer length of tube by, for example, cutting the tubing near seal 120 leaving extension 160 if necessary. Container 100 may then be, stored, transported, and the like until the contents 140 are withdrawn.
(40) The contents 140 may be withdraw by any suitable means and can include puncturing or otherwise opening wall 145 allowing the contents 140 to escape or be removed. For example, seal 105 and any additional length 155 of elongate body 150 may be removed, and the contents 140 of void 130 removed by puncturing seal 110 with a needle where seal 110 is formed from a needle penetrable material such as EVA for example. By first removing seal 105 and opening void 125, the inner surfaces 1115 of void 125 which may be substantially sterile are exposed to the penetrating needle rather than the other surfaces outside of void 125 which may not be sterile. In this way, voids 125 and 135 may protect the surfaces of seals 115 and 110 opposite void 130 from contamination during transportation, handling, and storage of container 100.
(41) As discussed herein, in certain embodiments the sealing portions of the present invention may be formed using heat. It will be understood that any suitable technique for applying heat known to one skilled in the art may be utilized. In certain embodiments, heat may be directly applied using a heating element, for example a heated iron or bar. In some forms, the heating element is continuously heated. In some forms the heating element comprises an impulse sealer. In other embodiments, heat may be applied using: a laser, infrared radiation, hot gas, ultrasound energy, and/or radiofrequency (RF) energy.
(42) While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only one example may be shown and described and that all changes, equivalents, and modifications that come within the spirit of the inventions defined by following claims are desired to be protected. All publications, patents, and patent applications cited in this specification are herein incorporated by reference as if each individual publication, patent, or patent application were specifically and individually indicated to be incorporated by reference and set forth in its entirety herein.